Paper Details

  1. Home
  2. Paper Details

Tyrosine kinase inhibitors for the treatment of rheumatoid arthritis.

Author: Gomez-PuertaJose A, MócsaiAttila

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discusses the role of tyrosine kinase (TK) inhibitors, including fostamatinib and tofacitinib, in the treatment of rheumatoid arthritis. TK inhibitors have shown short-term good clinical responses in patients with active rheumatoid arthritis, comparable to TNF inhibitors. However, long-term safety profiles are unknown due to limited follow-up.
Paper Details　
Original Abstract of the Article :
Tyrosine kinases (TK) are enzymes capable of transferring phosphate groups to tyrosine residues in cytoplasmic proteins or the intracellular domains of transmembrane receptors. TK play critical roles in diverse biological functions including cellular processes such as adhesion, motility, proliferati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796894/

データ提供：米国国立医学図書館（NLM）

Tyrosine Kinase Inhibitors: New Weapons in the Arsenal Against Rheumatoid Arthritis

Imagine a battle against rheumatoid arthritis, where the body's own immune system is like a ferocious sandstorm, attacking the joints. Tyrosine kinase inhibitors (TKIs) are like powerful weapons, specifically designed to target key enzymes involved in this inflammatory process.

This study explores the potential of TKIs in treating rheumatoid arthritis, focusing on two promising candidates: fostamatinib and tofacitinib. These drugs are like strategically placed fortresses in the desert, aiming to dampen the inflammatory storm and restore balance.

A Promising New Frontier

The results show that these TKIs can effectively manage rheumatoid arthritis, offering a new hope for patients who have not responded well to traditional treatments. It's like discovering a hidden oasis in the desert, providing relief from the relentless heat of inflammation.

Health Implications and Practical Tips

While TKIs hold great promise for treating rheumatoid arthritis, it's important to be mindful of potential side effects, like any traveler navigating a desert needs to be prepared for challenges. Close monitoring and careful management are crucial, ensuring that the benefits of these drugs outweigh any risks.

Dr.Camel's Conclusion

The emergence of TKIs is a significant advancement in the battle against rheumatoid arthritis, offering new weapons to fight the relentless sandstorm of inflammation. However, as always, it's important to remember that the desert of medicine is vast and complex, and careful navigation is essential for achieving optimal outcomes.

Date :
  1. Date Completed 2014-01-13
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

23574525

DOI: Digital Object Identifier

PMC3796894

Related Literature

Article Analysis
・Side Effects of fostamatinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.